Standard BioTools (LAB) Short Interest Ratio & Short Volume → This AI Trade Machine Made 1,729%* (With 89% Wins) (From Prosper Trading Academy) (Ad) Free LAB Stock Alerts $2.44 +0.08 (+3.39%) (As of 04/26/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Standard BioTools Short Interest DataCurrent Short Volume11,280,000 sharesPrevious Short Volume10,230,000 sharesChange Vs. Previous Month+10.26%Dollar Volume Sold Short$31.25 millionShort Interest Ratio / Days to Cover5.5Last Record DateApril 15, 2024Outstanding Shares290,120,000 sharesFloat Size369,480,000 sharesShort Percent of Float3.05%Today's Trading Volume3,639,350 sharesAverage Trading Volume3,070,715 sharesToday's Volume Vs. Average119% Short Selling Standard BioTools ? Sign up to receive the latest short interest report for Standard BioTools and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatLAB Short Interest Over TimeLAB Days to Cover Over TimeLAB Percentage of Float Shorted Over Time Ad Prosper Trading AcademyThis AI Trade Machine Made 1,729%* (With 89% Wins)This A.I. trading software called out an options trade the other day with a nearly perfect historical win rate… And a cumulative gain of 1729%. How does it all work?Click Here To Get Your Free Copy Standard BioTools Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202411,280,000 shares $31.25 million +10.3%3.1%5.5 $2.77 3/31/202410,230,000 shares $27.72 million +10.5%2.7%4.7 $2.71 3/15/20249,260,000 shares $24.26 million +16.9%3.3%5 $2.62 2/29/20247,920,000 shares $17.82 million -1.7%2.8%4.8 $2.25 2/15/20248,060,000 shares $20.15 million +10.4%2.9%5.8 $2.50 1/31/20247,300,000 shares $16.57 million -4.8%2.6%5.7 $2.27 Get the Latest News and Ratings for LAB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Standard BioTools and its competitors with MarketBeat's FREE daily newsletter. 1/15/20247,670,000 shares $16.49 million +33.2%2.7%6.6 $2.15 12/31/20235,760,000 shares $12.73 million +11.2%2.0%5.9 $2.21 12/15/20235,180,000 shares $10.31 million +26.0%6.6%6.7 $1.99 11/30/20234,110,000 shares $10.60 million +13.9%5.1%6.3 $2.58 11/15/20233,610,000 shares $7.94 million +6.5%4.7%5.7 $2.20 10/31/20233,390,000 shares $6.75 million -18.7%4.4%5.8 $1.99 10/15/20234,170,000 shares $6.63 million +18.5%5.4%8 $1.59 9/30/20233,520,000 shares $10.21 million +28.5%4.6%9.1 $2.90 9/15/20232,740,000 shares $7.70 million +7.5%3.6%10.7 $2.81 8/31/20232,550,000 shares $7.65 million -2.7%3.3%11.1 $3.00 8/15/20232,620,000 shares $7.52 million +4.8%3.4%10 $2.87 7/31/20232,500,000 shares $6.13 million -4.6%3.3%9.1 $2.45 7/15/20232,620,000 shares $6.16 million -1.9%3.4%9 $2.35 6/30/20232,670,000 shares $5.15 million -4.3%3.5%9.3 $1.93 6/15/20232,790,000 shares $6.17 million +0.4%3.7%9.3 $2.21 5/31/20232,780,000 shares $6.53 million -12.0%3.7%9.1 $2.35 5/15/20233,160,000 shares $6.00 million -2.8%4.2%11.5 $1.90 4/30/20233,250,000 shares $5.53 million +2.5%4.3%14.2 $1.70 4/15/20233,170,000 shares $5.71 million +18.7%4.1%13.9 $1.80 3/31/20232,670,000 shares $5.21 million +2.7%3.5%10.6 $1.95 3/15/20232,600,000 shares $5.36 million -15.0%3.4%10.6 $2.06 2/28/20233,060,000 shares $5.57 million +12.9%4.0%12.3 $1.82 2/15/20232,710,000 shares $5.69 million -6.9%3.5%11.1 $2.10 1/31/20232,910,000 shares $5.82 million -2.0%3.8%11.4 $2.00 1/15/20232,970,000 shares $5.94 million -8.9%3.8%11.4 $2.00 12/30/20223,260,000 shares $3.81 million -3.3%4.2%13.4 $1.17 12/15/20223,370,000 shares $4.58 million +2.7%4.4%14 $1.36 11/30/20223,280,000 shares $4.56 million -4.9%4.2%12.2 $1.39 11/15/20223,450,000 shares $5.24 million +0.3%4.5%11.2 $1.52 10/31/20223,440,000 shares $4.06 million -5.0%4.5%9.6 $1.18 10/15/20223,620,000 shares $3.73 million +0.3%4.7%8.4 $1.03 9/30/20223,610,000 shares $3.97 million -5.5%4.7%7.7 $1.10 9/15/20223,820,000 shares $5.04 million +11.7%5.0%5 $1.32 8/31/20223,420,000 shares $4.82 million -14.3%4.5%4.2 $1.41This AI Trade Machine Made 1,729%* (With 89% Wins) (Ad)This A.I. trading software called out an options trade the other day with a nearly perfect historical win rate… And a cumulative gain of 1729%. How does it all work?Click Here To Get Your Free Copy LAB Short Interest - Frequently Asked Questions What is Standard BioTools' current short interest? Short interest is the volume of Standard BioTools shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 11,280,000 shares of LAB short. 3.05% of Standard BioTools' shares are currently sold short. Learn More on Standard BioTools' current short interest. What is a good short interest ratio for Standard BioTools? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LAB shares currently have a short interest ratio of 6.0. Learn More on Standard BioTools's short interest ratio. What is a good short interest percentage for Standard BioTools? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.05% of Standard BioTools' floating shares are currently sold short. Is Standard BioTools' short interest increasing or decreasing? Standard BioTools saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 11,280,000 shares, an increase of 10.3% from the previous total of 10,230,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Standard BioTools' float size? Standard BioTools currently has issued a total of 290,120,000 shares. Some of Standard BioTools' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Standard BioTools currently has a public float of 369,480,000 shares. How does Standard BioTools' short interest compare to its competitors? 3.05% of Standard BioTools' shares are currently sold short. Here is how the short interest of companies compare to Standard BioTools: Cytek Biosciences, Inc. (6.29%), Quanterix Co. (3.21%), EyePoint Pharmaceuticals, Inc. (13.12%), Pacific Biosciences of California, Inc. (18.11%), Adaptive Biotechnologies Co. (7.23%), Nautilus Biotechnology, Inc. (1.95%), Akoya Biosciences, Inc. (4.74%), Harvard Bioscience, Inc. (1.55%), Intevac, Inc. (3.09%), Luna Innovations Incorporated (7.80%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Standard BioTools stock? Short selling LAB is an investing strategy that aims to generate trading profit from Standard BioTools as its price is falling. LAB shares are trading up $0.08 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Standard BioTools? A short squeeze for Standard BioTools occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of LAB, which in turn drives the price of the stock up even further. How often is Standard BioTools' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LAB, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: CTKB Short Squeeze QTRX Short Squeeze EYPT Short Squeeze PACB Short Squeeze ADPT Short Squeeze NAUT Short Squeeze AKYA Short Squeeze HBIO Short Squeeze IVAC Short Squeeze LUNA Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:LAB) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe World's First "$20 Trillion Drug?"Behind the MarketsJeff Bezos Just Humiliated Elon MuskInvestorPlaceMan Who Predicted 2008: “This Will be Worse.”Altimetry